Novo Nordisk A/S (NVO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Novo Nordisk A/S

    NYSE: NVO · Real-Time Price · USD
    54.28
    -0.95 (-1.72%)
    At close: Sep 08, 2025, 3:59 PM
    53.28
    -1.84%
    Pre-market: Sep 09, 2025, 08:38 AM EDT

    Novo Nordisk A/S Balance Sheet Statement

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 15.65B 14.39B 12.65B 10.72B
    Short-Term Investments
    		 10.65B 15.84B 10.92B 6.76B
    Long-Term Investments
    		 2.68B 1.66B 1.34B 1.44B
    Other Long-Term Assets
    		 4.02B 1.43B 206M 267M
    Receivables
    		 87.41B 75.26B 57.51B 46.8B
    Inventory
    		 40.85B 31.81B 24.39B 19.62B
    Other Current Assets
    		 6.33B 2.34B 9.67B 7.85B
    Total Current Assets
    		 160.9B 139.65B 108.19B 85.59B
    Property-Plant & Equipment
    		 162.49B 90.96B 66.67B 55.36B
    Goodwill & Intangibles
    		 111.09B 60.41B 51.42B 43.17B
    Total Long-Term Assets
    		 304.9B 174.84B 133.06B 108.91B
    Total Assets
    		 465.8B 314.49B 241.26B 194.51B
    Account Payables
    		 28.85B 25.61B 15.59B 8.87B
    Deferred Revenue
    		 n/a n/a n/a 55.18B
    Short-Term Debt
    		 11.78B 5.3B 480M 12.86B
    Other Current Liabilities
    		 165.85B 38.14B 103.89B 21.78B
    Total Current Liabilities
    		 217.53B 169.66B 120.94B 99.52B
    Long-Term Debt
    		 84.25B 15.98B 20.77B 9.65B
    Other Long-Term Liabilities
    		 9.68B 7.58B 5.45B 360M
    Total Long-Term Liabilities
    		 104.78B 38.27B 36.83B 24.25B
    Total Liabilities
    		 322.31B 207.93B 157.77B 123.76B
    Total Debt
    		 102.79B 27.01B 25.78B 26.64B
    Common Stock
    		 446M 451M 456M 462M
    Retained Earnings
    		 144.45B 104.84B 80.59B 72B
    Comprehensive Income
    		 -1.41B 1.28B 2.45B -1.71B
    Shareholders Equity
    		 143.49B 106.56B 83.49B 70.75B
    Total Investments
    		 13.33B 17.5B 12.26B 8.21B

    Add to Watchlist